Deal Wires

Myriad Genetics acquires maker of blood test and rheumatoid arthritis app for $270 million

Thu, 06 Feb 2014 15:57:31 GMT
Molecular diagnostic company Myriad Genetics has acquired Crescendo Biosciences for $270 million, in cash, which included repayment of a $25 million loan that Myriad made to Crescendo in 2011. Investor Safeguard Scientifics has invested $11 million Crescendo Biosciences, giving it a 13 percent stake, and expect to earn $40 million as part of the deal. Following the acquisition, [...]
read more

Thermo Fisher completes $13.6bn Life Tech acquisition

Wed, 05 Feb 2014 06:30:00 GMT
Thermo Fisher Scientific has completed its acquisition of Life Technologies, a life sciences company, for approximately $13.6bn and the assumption of $1.5bn in net debt.
read more

Week in Review: Mindray Acquires Control of US-China IVD Company

Sun, 02 Feb 2014 08:59:01 GMT
Mindray Medical acquired a controlling stake in Shanghai Long Island Biotec, which makes thrombotic and hemostatic reagent products; Actavis continued its exit from China by selling its interest in a China JV to Zhejiang Chiral Medicine Chemicals; Biogen Idec out-licensed China rights for an eight-drug portfolio, including its flagship MS drugs, to UCB (Euronext: UCB) of Belgium; Wanbang Biopharma in-licensed China rights to a Sirona Biochem pre-clinical diabetes treatment, paying up to $9.5 million; AstraZeneca and the Shanghai Institutes of Biological Sciences agreed to collaborate on a basic research project in cardiovascular disease; Sinovac Biotech filed an application with the CFDA to begin clinical trials of its avian flu A(H7N9) vaccine; and BioTime of California began a concurrent study of its bladder cancer diagnostic test in the US and China. More details…. Stock Symbols: (NYSE: MR) (NYSE: ACT) (NSDQ: BIIB) (TSX: SBM; OTCQS: SRBCF) (NYSE: AZN) (NSDQ: SVA) (NYSE: BTX) Share this with colleagues: // //  
read more

Thermo Fisher Sells Assets to GE Healthcare for $1.1B

Fri, 10 Jan 2014 07:00:00 GMT
Thermo Fisher Scientific is selling three business lines to GE in a $1.1 billion deal intended to expedite European Commission approval for its $13.6 billion acquisition of Life Technologies.
read more

BioClinica and CCBR-Synarc to merge with Water Street, JLL and Ampersand sharing ownership

Thu, 16 Jan 2014 12:30:35 GMT
BioClinica and CCBR-Synarc have agreed to merge with Water Street, JLL and Ampersand sharing ownership.
read more

Carlyle Group makes binding offer to acquire J&J’s Ortho-Clinical Diagnostics

Fri, 17 Jan 2014 11:34:37 GMT
Johnson & Johnson has received a binding offer from the Carlyle Group to acquire its Ortho-Clinical Diagnostics business for $4.15 billion. Ortho-Clinical Diagnostics delivers in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner.
read more

Carlyle Group to buy Johnson & Johnson's diagnostic unit for $4.15bn

Fri, 17 Jan 2014 06:30:00 GMT
The Carlyle Group has agreed to buy Johnson & Johnson's Ortho-Clinical Diagnostics (OCD) business for $4.15bn.
read more

BioClinica, CCBR-SYNARC To Merge

Sat, 18 Jan 2014 08:58:08 GMT
BioClinica and CCBR-SYNARC have signed an agreement to merge their companies
read more

BioMerieux Finalizes BioFire Diagnostics Acquisition

Thu, 16 Jan 2014 20:09:04 GMT
  read more
read more

CytoCore, Inc. To Acquire

Mon, 13 Jan 2014 00:00:00 GMT
read more